Federated Hermes’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.84K Sell
1,816
-397
-18% -$1.83K ﹤0.01% 1857
2026
Q1
$8.34K Buy
+2,213
New +$11.9K ﹤0.01% 1857
2023
Q4
Sell
-60,000
Closed -$202K 2189
2023
Q3
$202K Buy
60,000
+30,000
+100% +$197K ﹤0.01% 1526
2023
Q2
$248K Hold
30,000
﹤0.01% 1518
2023
Q1
$262K Buy
30,000
+4,000
+15% +$44.4K ﹤0.01% 1550
2022
Q4
$317K Sell
26,000
-4,000
-13% -$38K ﹤0.01% 1470
2022
Q3
$191K Buy
+30,000
New +$254K ﹤0.01% 1523

Other funds holding SGHT

Federated Hermes's SGHT Position: Q2 2026 in Review

Federated Hermes reduced its Sight Sciences (SGHT) stake by 18% in Q2 2026, selling an estimated $1.83K and leaving 1,816 shares worth $9.84K. The position accounts for ﹤0.01% of the portfolio, ranked #1857.

Federated Hermes first reported a position in SGHT in Q3 2022 and has held it in 7 quarters since. The position peaked at $317K in Q4 2022. 112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • Federated Hermes held 1,816 shares of Sight Sciences worth $9.84K as of Q2 2026.
  • Federated Hermes sold 397 Sight Sciences shares in Q2 2026, an estimated $1.83K.
  • Sight Sciences made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1857 holding.
  • Federated Hermes first reported a position in Sight Sciences in Q3 2022 and has held it in 7 quarters since.
  • Federated Hermes's Sight Sciences position peaked at $317K in Q4 2022.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.